GlassScriptPhysician profile
Dan Nicolas Tran
NPI 1215972336
$6,561.11
in general payments reported to CMS, 2019-2025
13 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.99 · 2022: $16.09 · 2023: $6,135 · 2024: $66.47 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $504.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,127.00 | 2023-2025 | Davinci Xi |
| Hologic Sales and Service, LLC | $152.58 | 2025 | Magseed, Sentimag, Magtrace |
| Millicent US INC | $42.38 | 2024-2025 | Intrarosa |
| Ethicon US, LLC | $40.31 | 2021-2023 | Vistaseal |
| Lifenet Health | $34.12 | 2024 | Theragenesis Wound Matrix |
| Baxter Healthcare | $25.51 | 2023 | Tisseel |
| Guard Medical INC. | $23.84 | 2023 | Npseal (5), Npseal Large, Npseal Medium |
| Merit Medical Systems INC | $23.35 | 2023 | Savi Scout |
| Davol INC. | $23.34 | 2021 | |
| Abbvie INC. | $20.26 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Medtronic, INC. | $19.23 | 2023 | Endoflip |
| Allergan, INC. | $16.09 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.10 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.